SG/CALL/STRYKER CORP./420/0.1/20.12.24 Stock

Warrant

DE000SW7ETR2

Real-time Bid/Ask 05:57:32 2024-07-08 am EDT
0.27 EUR / 0.38 EUR +41.30% Intraday chart for SG/CALL/STRYKER CORP./420/0.1/20.12.24
Current month-23.33%
1 month-34.29%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-08 0.27 +17.39%
24-07-05 0.23 +9.52%
24-07-04 0.21 -19.23%
24-07-03 0.26 -3.70%
24-07-02 0.27 -18.18%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 04:16 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SW7ETR
ISINDE000SW7ETR2
Date issued 2024-03-07
Strike 420 $
Maturity 2024-12-20 (166 Days)
Parity 10 : 1
Emission price 1.26
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.25
Lowest since issue 0.19
Spread 0.11
Spread %28.21%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
337.2 USD
Average target price
372.7 USD
Spread / Average Target
+10.52%
Consensus